Home   >  
MAPK Pathway
p38 MAPK

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

p38 MAPK

Chemical Structure Cat. No. Product Name CAS No.
SD-06 Chemical Structure
BCP21625 SD-06 271576-80-8
SD-06 is a MAPK p38 alpha inhibitor for the treatment of arthritis.
SB202190 HCl Chemical Structure
BCP21617 SB202190 HCl 350228-36-3
SB 202190 inhibits p38 and p38β2 with IC50 values of 50 nM and 100 nM. respectively.
R1487 Chemical Structure
BCP29574 R1487 449811-92-1
R1487 is a p38 MAP kinase inhibitor with an IC50 of 10nM.
UM164 Chemical Structure
BCP29207 UM164 903564-48-7
UM164 is a movel potent, dual c-Src/p38 with Kd of 2.7 nM (c-Src), potently inhibits both p38α and p38β; inhibits c-Src autophosphorylation in TNBC cell lines.
VX 702 Chemical Structure
BCP28564 VX 702 745833-23-2
VX-702, one of a series of second-generation, is an orally active p38 MAP kinase inhibitors, for the potential treatment of inflammation, rheumatoid arthritis and cardiovascular diseases.
SB-681323 Chemical Structure
BCP23819 SB-681323 444606-18-2
SB-681323, also known as Dilmapimod and GW-681323 , is p38 MAPK inhibitor.
p38 MAPK-IN-1 Chemical Structure
BCP24818 p38 MAPK-IN-1 1006378-90-0
p38 MAPK-IN-1 is a novel potent and selective inhibitor of p38 MAPK with IC50 of 68 nM, shows sustained levels, low clearance and good bioavailability.
Dehydrocorydaline chloride Chemical Structure
BCP24819 Dehydrocorydaline chloride 10605-03-5
Dehydrocorydaline chloride is an alkaloidal that has anti-inflammatory and anti-cancer activities.
Acumapimod Chemical Structure
BCP29101 Acumapimod 836683-15-9
Acumapimod (BCT197) is an orally active p38 MAP kinase inhibitor, with an IC50 of less than 1 μM for p38α.
TA-01 Chemical Structure
BCP24229 TA-01 1784751-18-3
TA-01 is a potent CK1 and p38 MAPK inhibitor, with IC50s of 6.4 nM, 6.8 nM, 6.7 nM for CK1ε, CK1δ and p38 MAPK, respectively.
123下一页共 29 条记录 1 / 3 页